Autonomic dysreflexia and bladder filling speed in people with spinal cord injury.
Official title: Autonomic Dysreflexia Clinical Characteristics According to the Filling Speed in Urodynamics in Individuals With Spinal Cord Injuries
Run by Pusan National University Yangsan Hospital · NCT06211491 · Data updated 2026-11-12
Researchers will test whether different bladder filling speeds during urodynamic testing change how often or how severely autonomic dysreflexia happens in people with chronic spinal cord injury.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Pusan National University Yangsan Hospital Academic / other |
| Locations | 1 site (Yangsan, Gyeongsangnam-do) |
| Status | Recruiting |
| Started | January 8, 2025 |
| Main results expected | August 30, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | January 14, 2026 |
| Trial ID | NCT06211491 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
People with chronic spinal cord injury (≥6 months) at neurological level C1–T6 with AIS A or B who previously had autonomic dysreflexia triggered by bladder filling and can safely undergo urodynamic testing.
✕Probably not a fit
Patients with active urinary tract infection, hemodynamic instability, or persistent high systolic blood pressure during testing (or those with different injury levels/less severe impairment) are unlikely to benefit from the study findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study will compare the prevalence and characteristics of autonomic dysreflexia (AD) during standardized urodynamic tests performed with different bladder filling (injection) speeds in people with chronic spinal cord injury. Eligible participants are at least six months post-injury with neurological levels C1–T6 and AIS A or B and a prior urodynamic test showing AD triggered by bladder fullness; investigators will record blood pressure responses and bladder pressures during testing. The analysis will determine whether filling speed or bladder expansion (and patient factors such as age and maximum detrusor pressure) more strongly predicts AD frequency and severity. For safety, patients with persistent systolic blood pressure ≥150 mmHg during testing, hemodynamic instability, or active urinary tract infection will be excluded.
Why it matters
Potential benefit: If successful, the findings could help make urodynamic testing safer by identifying filling rates or conditions that reduce the risk or severity of AD for people with spinal cord injury.
How similar studies have gone: Previous reports suggest urethral or sphincter stimulation, age, and maximum bladder pressure may influence AD more than filling speed, so while related observations exist this study addresses a largely unquantified effect of filling rate.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients with chronic spinal cord injury 6 months after receiving the award 2. Patients with confirmed AD due to bladder fullness in previous urodynamic test 3. Patients confirmed to have neurological damage level C1-T6, AIS A or B Exclusion Criteria: 1. Patients who cannot perform the test because their systolic blood pressure remains at 150 mmHg during the urodynamic test 2. Patients who cannot undergo testing due to hemodynamic instability 3. Patients who cannot undergo testing due to overt urinary tract infection
Where it's running
-
Pusan National University Yangsan Hospital
Yangsan, Gyeongsangnam-do, South Korea Recruiting
Study contacts
- Principal investigator: Sungchul Huh, Ph.D — Pusan National University Yangsan Hospital
- Study coordinator: Sungchul Huh, Ph.D
- Email: dr.huhsc@gmail.com
- Phone: 055-360-4000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using mild intermittent hypoxia to prevent autonomic dysfunction in spinal cord injury patients
This study is testing if mild intermittent hypoxia can help people with spinal cord injuries improve their blood pressure control and overall health by preventing autonomic dysfunction.
-
Transcutaneous spinal cord stimulation with 4-aminopyridine and intensive rehab for chronic spinal cord injury
This pilot study tests whether combining noninvasive spinal stimulation, dalfampridine, and rigorous rehab is safe and feasible for adults with chronic spinal cord injury and whether it can help improve movement and walking.
-
NG004 for incomplete cervical spinal cord injury
This trial tests NG004 versus placebo to see if it is safe and helps motor function and daily life in adults with acute incomplete cervical spinal cord injury.
-
Robot-assisted training for arm and leg movement after stroke or injury
This study tests whether adding ZEPU-AI robotic training to usual therapy is safe and helps adults with arm or leg movement problems from stroke, spinal cord injury, brain injury, or orthopedic conditions.
-
ZEPU-AI3 Lower Limb Feedback Training and Evaluation Robot in Rehab
This pilot trial tests whether adding the ZEPU-AI3 robotic leg training with real-time feedback to standard rehab helps adults with lower limb motor problems from stroke, spinal cord injury, or similar conditions.
-
Combined magnetic stimulation and ultrasound for detrusor overactivity in spinal cord injury
This study tests whether using high-frequency sacral nerve stimulation together with bladder-directed ultrasound can reduce involuntary bladder contractions and improve bladder function in people with spinal cord injury.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.